MedTrace Logo

Guideline for Hometitration With Duodopa for Parkinson Patients

NCT04196647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-11-02

No results posted yet for this study

Summary

The purpose of this study is to

1. Create a guide for hometitration of Duodopa for patients with Parkinson's disease
2. Outline which patients could be considered for "hometitration"

Conditions

  • Parkinson Disease

Interventions

OTHER

Home titration

Patients have their initial dosage titration of duodopa done in their own home, supported by one visit from nursing staff, and one video consultation a day

Sponsors & Collaborators

  • AbbVie

    collaborator INDUSTRY

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Bo Biering-Sørensen, Director · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04196647 on ClinicalTrials.gov